Overview of Diagnosis and Management of Metastatic Disease to Bone

被引:1
作者
Yu, Hsiang-Hsuan Michael [1 ]
Tsai, Ya-Yu [2 ]
Hoffe, Sarah E. [1 ]
机构
[1] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Radiat Oncol, Tampa, FL 33612 USA
[2] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol & Genet, Tampa, FL 33612 USA
关键词
POSITRON-EMISSION-TOMOGRAPHY; RANDOMIZED-TRIAL; 8; GY; ZOLEDRONIC ACID; CANCER-PATIENTS; BREAST-CANCER; SKELETAL COMPLICATIONS; RADIOTHERAPY TRIALS; MULTIPLE FRACTIONS; DOUBLE-BLIND;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Bone metastases occur frequently in patients with advanced cancer and are a serious complication of cancer. The decision to treat is often individualized, based on each patient's clinical presentation, life expectancy, and quality of life. Methods: We reviewed the current literature pertaining to management of metastatic disease to bone, and the medical, radiotherapeutic, and surgical treatment options for management of bone metastasis are discussed. Results: Current management of skeletal metastasis includes analgesia, systemic therapy, radiation therapy, and surgery. We propose treatment algorithms for management of vertebral and nonvertebral bone metastases and suggest individualized interventions based on clinical presentation. Conclusions: Management of bone metastases is complex and requires a multidisciplinary approach. The goal of treatment is often palliative, and intervention and treatment regimens should be individualized based on the specific clinical presentation of each patient.
引用
收藏
页码:84 / 91
页数:8
相关论文
共 75 条
[41]   Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial [J].
Patchell, RA ;
Tibbs, PA ;
Regine, WF ;
Payne, R ;
Saris, S ;
Kryscio, RJ ;
Mohiuddin, M ;
Young, B .
LANCET, 2005, 366 (9486) :643-648
[42]  
PEREZ CA, 1993, CANCER-AM CANCER SOC, V71, P1110, DOI 10.1002/1097-0142(19930201)71:3+<1110::AID-CNCR2820711433>3.0.CO
[43]  
2-5
[44]   BONE-SCINTIGRAPHY AND MULTIMODALITY IMAGING IN BONE NEOPLASIA - STRATEGIES FOR IMAGING IN THE NEW HEALTH-CARE CLIMATE [J].
POMERANZ, SJ ;
PRETORIUS, HT ;
RAMSINGH, PS .
SEMINARS IN NUCLEAR MEDICINE, 1994, 24 (03) :188-207
[45]  
PORTER AT, 1993, SEMIN ONCOL, V20, P38
[46]  
Resnick D, 1988, DIAGNOSIS BONE JOINT, P3945
[47]   STRONTIUM-89 THERAPY FOR THE PALLIATION OF PAIN DUE TO OSSEOUS METASTASES [J].
ROBINSON, RG ;
PRESTON, DF ;
SCHIEFELBEIN, M ;
BAXTER, KG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (05) :420-424
[48]   INTRA AND INTEROBSERVER VARIABILITY IN CANCER-PATIENTS PERFORMANCE STATUS ASSESSED ACCORDING TO KARNOFSKY AND ECOG SCALES [J].
ROILA, F ;
LUPATTELLI, M ;
SASSI, M ;
BASURTO, C ;
BRACARDA, S ;
PICCIAFUOCO, M ;
BOSCHETTI, E ;
MILELLA, G ;
BALLATORI, E ;
TONATO, M ;
DELFAVERO, A .
ANNALS OF ONCOLOGY, 1991, 2 (06) :437-439
[49]   Mechanisms of disease: Mechanisms of bone metastasis [J].
Roodman, GD .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (16) :1655-1664
[50]   Randomized trial of 8 Gy in 1 versus 20 Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases (Trans-Tasman Radiation Oncology Group, TROG 96.05) [J].
Roos, DE ;
Turner, SL ;
O'Brien, PC ;
Smith, JG ;
Spry, NA ;
Burmeister, BH ;
Hoskin, PJ ;
Ball, DL .
RADIOTHERAPY AND ONCOLOGY, 2005, 75 (01) :54-63